Caxton Corporation’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-262,969
| Closed | -$5.72M | – | 51 |
|
|
2021
Q4 | $5.72M | Sell |
262,969
-179,785
| -41% | -$3.91M | 4.67% | 7 |
|
|
2021
Q3 | $9.71M | Sell |
442,754
-1,205
| -0.3% | -$26.4K | 7.86% | 4 |
|
|
2021
Q2 | $8.65M | Hold |
443,959
| – | – | 5.92% | 7 |
|
|
2021
Q1 | $7.65M | Sell |
443,959
-200,000
| -31% | -$3.45M | 4.97% | 7 |
|
|
2020
Q4 | $10.3M | Hold |
643,959
| – | – | 6.43% | 6 |
|
|
2020
Q3 | $6.87M | Hold |
643,959
| – | – | 6.48% | 5 |
|
|
2020
Q2 | $7.79M | Hold |
643,959
| – | – | 8.22% | 4 |
|
|
2020
Q1 | $6.32M | Buy |
+643,959
| New | +$6.32M | 6.91% | 5 |
|
|
2018
Q4 | – | Sell |
-2,797
| Closed | -$190K | – | 31 |
|
|
2018
Q3 | $190K | Buy |
2,797
+1,954
| +232% | +$133K | 0.18% | 28 |
|
|
2018
Q2 | $100K | Sell |
843
-97
| -10% | -$11.5K | 0.04% | 22 |
|
|
2018
Q1 | $78K | Buy |
+940
| New | +$78K | 0.08% | 23 |
|
|
2016
Q1 | – | Sell |
-1,143
| Closed | -$688K | – | 21 |
|
|
2015
Q4 | $688K | Hold |
1,143
| – | – | 2.89% | 4 |
|
|
2015
Q3 | $938K | Buy |
+1,143
| New | +$938K | 1.27% | 3 |
|